Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By



This article was originally published in The Tan Sheet

Executive Summary

PFIZER's UNISOM ADVERTISING MOVING TO CLINE, DAVIS & MANN's new OTC unit effective Dec. 1. The ad agency's new OTC unit will begin official operations that day. In the meantime, the agency said it is hiring staff for the new division. The current ad agency handling the Unisom account is New York-based Avrett, Free & Ginsberg. Cline, Davis & Mann, New York, has appointed Senior VP and Management Supervisor Philip Roselin to manage the new OTC unit. Although staffers currently handling prescription product accounts at the medical specialty agency are expected to work with the new OTC unit, Cline, Davis said it plans to hire both account service personnel as well as creative staff to handle new OTC client accounts. The agency said it is currently in discussions with Pfizer about 1994 marketing plans for Unisom. The agency indicated that the ad campaign for the line, which includes a doxylamine-based sleep aid and a diphenhydramine/acetaminophen sleep aid for pain relief, will include television, radio and print ads. Unisom is currently the OTC division's only account although the agency said it is actively pursuing other OTC drug accounts. Cline, Davis & Mann already handles a number of prescription product accounts for Pfizer including Zithromax, Diflucan, Cardura and Unasyn. In addition, the agency handles professional advertising for Pfizer Consumer Healthcare's Plax mouth rinse. Cline, Davis & Mann also has a number of prescription product accounts with Rhone-Poulenc Rorer, Forest Labs and Parke-Davis.

You may also be interested in...

People In Brief

Perrigo promotes in pricing, planning

In Brief

Combe sells most of its OTC brands

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts